REVELATION BIOSCIENCES, INC.

Revelation Biosciences, Inc. (Nasdaq: REVB) is a clinical-stage biopharmaceutical company headquartered in San Diego, California, focused on developing therapies that engage the innate immune system to address infectious diseases and related conditions. The company entered public markets through a SPAC business combination and was an active SEC reporting issuer at the time of its Form 10-Q filing on August 23, 2021, which captured quarterly financial results for this healthcare and life sciences operator. The filing reflects the company's financial position during the early phase of its public market life, as it pursued clinical development programs targeting innate immunity pathways. Sign up at SpacDesk for full filing histories, deal data, and analytics on REVB and hundreds of other SPAC transactions.